Chronos Archive seal
The Human Record

Ray Charles

Case HR-ML009 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
September 23, 1930 – June 10, 2004
Synthetic DOB
1960-09-23
Index visit
2026-03-03 at age 65
Synthetic MRN
HR-ML009-SYN

Teaching objective: Disability-competent primary care for a man blind since childhood (introductions and spoken orientation, describing each step of the examination, accessible electronic documents, braille and audio medication labels, and fall prevention), recovery-oriented care for an opioid use disorder in sustained remission for three decades (naloxone, relapse-prevention discussion, and a plan for any future pain that protects his recovery, in non-stigmatizing language), depression screening and a structured safety assessment, and eye care for blind eyes limited to what can help him (comfort, pain, and the place of pressure checks) on the CMID glaucoma and depression monographs with AAO, ASAM, and VA/DoD guidance.

Historical timeline

DateEventClaims
September 23, 1930Born Ray Charles Robinson in Albany, Georgia.CLM-0001
1935Began to lose his sight; his younger brother drowned the same year.CLM-0003, CLM-0007
1937Blind by age seven; enrolled at the Florida School for the Deaf and Blind.CLM-0003
1945His mother died.CLM-0007
1964Arrested for heroin possession; later admitted addiction since the late 1940s.CLM-0005
1965Stopped heroin after rehabilitation at a California sanitarium.CLM-0005, CLM-0006
June 10, 2004Died at his home in Beverly Hills.CLM-0002

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Ray Charles Robinson was born in Albany, Georgia, on September 23, 1930; his mother moved him as an infant to Greenville, a small town in north Florida. confirmed Ray Charles (1930-2004) supports
D Ray Charles died at his home in Beverly Hills, California, on June 10, 2004, of acute liver disease, according to his spokesman.
Record the death as a fact without detail; the episode records no liver diagnosis.
confirmed Ray Charles (1930-2004) supports
Legendary musician Ray Charles dies at 73 supports
D Charles began to lose his sight at about age five and was blind by age seven; after he was declared legally blind, he was enrolled at the Florida School for the Deaf and Blind in St. Augustine, where he remained for nine years.
The anchor for the blindness of both eyes since childhood. The sources do not grade the residual vision; the record treats it as total blindness.
confirmed Ray Charles (1930-2004) supports
Legendary musician Ray Charles dies at 73 supports
R The cause of his blindness is uncertain. It is described as probably congenital juvenile glaucoma, and glaucoma is often mentioned as the cause, but Charles said that nothing was ever diagnosed.
Retrospective interpretation; glaucoma is not coded as a diagnosis.
possible Ray Charles (1930-2004) supports
Legendary musician Ray Charles dies at 73 disputes
D In 1964 Charles was arrested for possession of heroin, and he later admitted that he had been addicted since the late 1940s. After a period of rehabilitation at a California sanitarium he stopped using drugs and received a five-year suspended sentence.
His own public admission and the documented rehabilitation; the anchor for the synthetic opioid use disorder in sustained remission.
confirmed Ray Charles (1930-2004) supports
D Charles struggled with heroin addiction for nearly 20 years and quit "cold turkey" in 1965, after an arrest at the Boston airport. He later became reluctant to discuss his drug use, fearing it would taint how people viewed his work.
Supports the long remission and the recovery-oriented, non-stigmatizing approach in the episode.
confirmed Legendary musician Ray Charles dies at 73 supports
D In the year Charles began to lose his sight, his younger brother drowned. His mother died in 1945.
Family history; no cause of the mother's death is given.
confirmed Ray Charles (1930-2004) supports
Legendary musician Ray Charles dies at 73 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Blindness of both eyes since childhood, no light perception; cause never diagnosed active confirmed both_with_link CLM-0003, CLM-0004
S Opioid use disorder (heroin), in sustained remission for more than thirty years, without medication treatment active confirmed both_with_link CLM-0005, CLM-0006

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-03-03 Hemoglobin [Mass/volume] in Blood 14.2 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-03-03 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-03-03 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-03-03 Creatinine [Mass/volume] in Serum or Plasma 0.98 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-03-03 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-03-03 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-03-03 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-03-03 Cholesterol [Mass/volume] in Serum or Plasma 186 mg/dL
Reference <=200 mg/dL
http://loinc.org · 2093-3
S 2026-03-03 Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-03-03 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 110 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2026-03-03 Triglyceride [Mass/volume] in Serum or Plasma 110 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-03-03 Hemoglobin A1c/Hemoglobin.total in Blood 5.5%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-03-03 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 2026-03-03 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 2026-03-03 Total score [DAST-10] 0 http://loinc.org · 82667-7
S 2026-09-01 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 2026-10-06 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-06 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 2026-10-06 Total score [DAST-10] 0 http://loinc.org · 82667-7

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-03-03Body height178 cm8302-2S
2026-03-03Body weight80 kg29463-7S
2026-03-03Body mass index (BMI) [Ratio]25.2 kg/m239156-5S
2026-03-03Systolic blood pressure128 mm[Hg]8480-6S
2026-03-03Diastolic blood pressure78 mm[Hg]8462-4S
2026-03-03Heart rate68 /min8867-4S
2026-03-03Respiratory rate14 /min9279-1S
2026-03-03Body temperature36.7 Cel8310-5S
2026-03-03Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-03-31Body height178 cm8302-2S
2026-03-31Body weight80.2 kg29463-7S
2026-03-31Body mass index (BMI) [Ratio]25.3 kg/m239156-5S
2026-03-31Systolic blood pressure126 mm[Hg]8480-6S
2026-03-31Diastolic blood pressure76 mm[Hg]8462-4S
2026-03-31Heart rate66 /min8867-4S
2026-03-31Respiratory rate14 /min9279-1S
2026-03-31Body temperature36.6 Cel8310-5S
2026-03-31Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-02Body height178 cm8302-2S
2026-06-02Body weight79.8 kg29463-7S
2026-06-02Body mass index (BMI) [Ratio]25.2 kg/m239156-5S
2026-06-02Systolic blood pressure124 mm[Hg]8480-6S
2026-06-02Diastolic blood pressure78 mm[Hg]8462-4S
2026-06-02Heart rate68 /min8867-4S
2026-06-02Respiratory rate14 /min9279-1S
2026-06-02Body temperature36.7 Cel8310-5S
2026-06-02Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-01Body height178 cm8302-2S
2026-09-01Body weight80 kg29463-7S
2026-09-01Body mass index (BMI) [Ratio]25.2 kg/m239156-5S
2026-09-01Systolic blood pressure128 mm[Hg]8480-6S
2026-09-01Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-01Heart rate66 /min8867-4S
2026-09-01Respiratory rate14 /min9279-1S
2026-09-01Body temperature36.6 Cel8310-5S
2026-09-01Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-06Body height178 cm8302-2S
2026-10-06Body weight80.4 kg29463-7S
2026-10-06Body mass index (BMI) [Ratio]25.4 kg/m239156-5S
2026-10-06Systolic blood pressure126 mm[Hg]8480-6S
2026-10-06Diastolic blood pressure78 mm[Hg]8462-4S
2026-10-06Heart rate68 /min8867-4S
2026-10-06Respiratory rate14 /min9279-1S
2026-10-06Body temperature36.7 Cel8310-5S
2026-10-06Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Routine outpatient care. Crisis resources, including the 988 Suicide & Crisis Lifeline, given in an accessible electronic format and saved in his phone; safety reviewed at each visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Visit summaries, results, and medicine information delivered in an accessible electronic format, and medicine labels in braille or audio, by the four-week visit2026-03-31completedVisit summaries sent as accessible documents; the pharmacy provides audio labels and a braille label on the naloxone
Naloxone at home and in his travel bag, with a tactile label, and the people he travels with shown how to use it, by the three-month visit2026-06-02completedNaloxone in both places; travel staff shown how to use it
Stay in sustained remission, with no return to opioid use, through six months2026-09-01completedNo opioid use; DAST-10 0 at intake and no use reported at each visit
No falls through six months2026-09-01completedNo falls
A written plan for any future acute pain or surgery that uses non-opioid treatment first and builds in safeguards if an opioid is ever needed, by the six-month visit2026-09-01completedPlan written with him and saved in an accessible format

Interventions

InterventionStatusGuideline
Disability-competent care at every visit: introductions and spoken orientation, describing each step of the examination, offering an arm for guiding, and all documents in an accessible electronic formatcompletedGL-AAO-VISREHAB-2023
Ophthalmology consultation to examine the blind eyes for comfort and complications and to advise on pressure checks and surveillancecompletedGL-AAO-POAG-2025, GL-CMID-2026
Recovery-oriented care: ask about cravings, triggers, and any return to use at each visit in a non-judgmental way; naloxone at home and when traveling; recovery supports he can reach; and a written plan for any future paincompletedGL-SUD-2021, GL-ASAM-OUD-2020
Depression screening with the PHQ-9 at intake and at six months, PHQ-2 at the wellness visit, and a safety review with the 988 Suicide & Crisis Lifeline at each visitcompletedGL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024
Medicine labeling: audio labels from the pharmacy, a braille label on the naloxone, and the same pharmacy for every prescriptioncompletedGL-AAO-VISREHAB-2023
Fall prevention: CDC STEADI screen at each visit, keeping the home layout unchanged, and a sighted guide in unfamiliar placescompletedGL-AAO-VISREHAB-2023

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Ray Charles (1930-2004) New Georgia Encyclopedia (Georgia Humanities) scholarly
SRC-0002 Legendary musician Ray Charles dies at 73 Associated Press (Seattle Times archive) other
SRC-0003 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review.
provenance reviewnot_startedRecent-death rule: only what Charles made public and what was reported at his death is used, from the New Georgia Encyclopedia and the AP obituary. The cause of his blindness is graded R.
safe messaging reviewnot_startedSubstance-use claims are marked sensitive; recovery is described in person-first, non-stigmatizing language; the safety assessment records no current risk and gives the 988 Suicide & Crisis Lifeline; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.